Summary The operating results for the year ended 31 December 2018 were that the Company generated total revenues of 8,813 million Baht, a decrease of 458 million Baht or 5% as compared to 2017. This

due to the Company incurred cost of fund from debentures and loan increase. Summary of Financial Statement of Positions 31-Dec-17 31-Dec-18 Change MB % MB % MB % Assets Cash and cash equivalents 6.0 0.2

expected due to declining global trade volumes and the slower economic growth of major trading partners, which were affected by trade tensions between the US and China. Export growth has been negatively

on dissolution of Solvay Biochemicals (Taixing) Limited amounting to 89 MB from other comprehensive income to the profit of the year 2018. Summary of Performance For the year 2019, the Company and its

December 31, 2017. The Group's sales and net profit totaled Bt14,195.4 million and Bt2,544.5 million, respectively, compared to Bt13,797.5 million and Bt3,038.7 million in fiscal year 2016. A summary of the

baht, which was higher than 2016 of 25.2 million baht or 112.4%. Financial cost increased due to the Company incurred more debentures and loan from financial institution. Summary of Financial Statement

baht or 112.4%. Financial cost increased due to the Company incurred more debentures and loan from financial institution. Summary of Financial Statement of Position 31-Dec-16 31-Dec-17 Change MB % MB

) Director & Senior Vice President Nawarat Patanakarn Public Company Limited NAWARAT PATANAKARN PUBLIC COMPANY LIMITED SUMMARY OF FINANCIAL POSITION AND PERFORMANCE FOR THE PERIOD OF ONE YEAR ENDED DECEMBER 31

control such as utilities expenses and marketing expenses. Summary of Financial Statement of Positions 31 Dec 2018 31 Mar 2019 Change MB. % MB. % MB. % Cash and cash equivalents 21.4 0.9% 23.4 1.0% 2.0 9.3

Limited (“the Company”) would like to submit this Management Discussion and Analysis for the three-month period ended 31 March 2019 with details as follows: Summary overview In the first quarter of 2019